Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
J Am Coll Cardiol. 2020 Nov 10;76(19):2226-2234. doi: 10.1016/j.jacc.2020.09.533.
Case reports and referral-based studies suggest spontaneous coronary artery dissection (SCAD) is associated with autoimmune diseases and causes 2% to 4% of acute coronary syndromes.
This study determined the association of SCAD with autoimmune diseases, together with incidence and recurrence, in a population-based study.
This case-control study took place from 1995 to 2018 within the Rochester Epidemiology Project. The study identified cases with SCAD from diagnosis codes and verified them using coronary angiography images, matching each case to 3 control subjects on age, sex, county, and years of medical history. Autoimmune disease history came from a validated, code-based definition. A multivariable logistic regression model calculated the odds ratio (OR) for SCAD among patients with a history of autoimmune disease, adjusting for race and body mass index.
The study identified 114 cases with SCAD (mean age 51 years and 90% women) and 342 matched control subjects. Autoimmune disease occurred in 13 (11%) cases with SCAD and 40 (12%) control subjects (p = 0.93). Even after adjustment, autoimmune diseases were not associated with SCAD (OR: 0.81; 95% confidence interval [CI]: 0.40 to 1.66). SCAD incidence between 2010 and 2018 (2.7 per 100,000; 95% CI: 1.7 to 3.7) was 10-fold higher than the incidence between 1995 and 2009 (0.3 per 100,000; 95% CI: 0.0 to 0.6). SCAD recurrence was 10% (95% CI: 3% to 16%) at 5 years.
These findings suggested SCAD pathogenesis is noninflammatory and screening for autoimmune diseases based on SCAD alone is not warranted. The code-based incidence of SCAD has increased over time, highlighting the importance of considering SCAD among patients with acute coronary syndromes.
病例报告和基于转诊的研究表明,自发性冠状动脉夹层(SCAD)与自身免疫性疾病有关,占急性冠状动脉综合征的 2%至 4%。
本研究通过基于人群的研究,确定 SCAD 与自身免疫性疾病的关联,以及其发病率和复发率。
该病例对照研究于 1995 年至 2018 年在罗切斯特流行病学项目中进行。通过诊断代码确定 SCAD 病例,并使用冠状动脉造影图像进行验证,将每个病例与年龄、性别、县和病史年限相匹配的 3 名对照进行匹配。自身免疫性疾病史来源于经过验证的基于代码的定义。多变量逻辑回归模型计算了有自身免疫性疾病史的患者中 SCAD 的比值比(OR),并调整了种族和体重指数。
研究共确定了 114 例 SCAD(平均年龄 51 岁,90%为女性)和 342 名匹配的对照。SCAD 中有 13 例(11%)和 40 例(12%)对照患者有自身免疫性疾病(p=0.93)。即使经过调整,自身免疫性疾病与 SCAD 无关(OR:0.81;95%置信区间 [CI]:0.40 至 1.66)。2010 年至 2018 年 SCAD 的发病率为每 10 万人 2.7 例(95%CI:1.7 至 3.7),是 1995 年至 2009 年发病率每 10 万人 0.3 例(95%CI:0.0 至 0.6)的 10 倍。SCAD 的 5 年复发率为 10%(95%CI:3%至 16%)。
这些发现表明 SCAD 的发病机制是非炎症性的,因此仅基于 SCAD 筛查自身免疫性疾病是没有必要的。基于代码的 SCAD 发病率随着时间的推移而增加,这凸显了在急性冠状动脉综合征患者中考虑 SCAD 的重要性。